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ABSTRACT: 
First, the developmental toxic potential of n-butyl acetate (BA) was examined in Sprague-
Dawley rats following whole body inhalation exposure, 6 h day-1, from day 6 to 20 of 
gestation, at concentrations of 0, 500, 1000, 2000 and 3000 ppm. Maternal toxicity was 
evidenced by significant decreases in body weight gain at 2000 and 3000 ppm, and by 
reduced food consumption at 1000 ppm and higher concentrations. The effects on prenatal 
development were limited to a significant decrease in fetal weight at 3000 ppm. Thus, inhaled 
BA was not a selective developmental toxicant. In the second part of this study, the 
developmental toxic effects of simultaneous exposures to ethylbenzene (EB) and BA, or to 
toluene (TOL) and BA were evaluated. Pregnant rats were administered EB (0, 250 or 1000 
ppm) and BA (0, 500 or 1500 ppm), or TOL (0, 500 or 1500 ppm) and BA (0, 500, 1500 
ppm), separately and in combinations, using a 2 × 2 factorial design. The maternal weight 
gain was reduced after exposure to 1000 ppm EB, to 1500 ppm BA, or to 1500 ppm TOL, 
either alone or in binary combinations. A significant reduction of fetal weight was associated 
with exposure to 1000 ppm EB alone, to either mixtures of EB with BA, or to 1500 ppm TOL 
alone or combined with BA at either concentration. No embryolethal or teratogenic effects 
were observed whatever the exposure. There was no evidence of interaction between EB and 
BA or between TOL and BA in causing maternal or developmental effects. Copyright © 2006 
John Wiley & Sons, Ltd. 
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Introduction 
Occupational exposure to organic solvents during pregnancy has been associated with an 
increased risk of birth defects, including spontaneous abortion and intrauterine growth 
retardation (Schardein, 2000; Robert- Gnansia and Saillenfait, 2002). In most manufacturing 
and processing units, solvents are used in mixtures, and women are rarely exposed to a single 
compound in their working environment. 
Ethylbenzene (EB) is a high production volume substance. It is mainly used in the 
manufacture of styrene and as a solvent. It is a component of mixed xylenes and gasoline 
(World Health Organization, 1996). The effects of inhaled EB on reproduction and offspring 
development have been well characterized in rats (Ungvary and Tatrai, 1985; Faber et al., 
2006). When Sprague-Dawley rats were exposed to 100 or 1000 ppm EB for 7 h day-1, 
during gestational day (GD) 1–19, an increased incidence of fetuses with skeletal variations 
(supernumerary ribs) was observed at 1000 ppm, in the presence of maternal effects (i.e. 
increased liver weight) (Andrew et al., 1981; Hardin et al., 1981). Maternal and fetal toxicity 
was reported in Sprague-Dawley rats following exposure to 1000 or 2000 ppm EB, 6 h day-1, 
from GD 6 to 20 (Saillenfait et al., 2003). Developmental effects included a reduction in fetal 
body weight at 2000 and 3000 ppm, and an increased incidence of fetuses with skeletal 
variations at 2000 ppm. The no-observed-adverse-effect-level (NOAEL) was set at 500 ppm. 
Toluene (TOL) also belongs to the large family of aromatic hydrocarbons. It is used as an 
intermediate in the production of other chemicals, and as a solvent in paints, inks, thinners, 
coatings, adhesives and degreasers. It is also a constituent of gasoline. In 1995, the production 
volume of toluene in the European Union was 2600 kTonnes (European Chemicals Bureau, 
2003). Limited data have suggested an increased risk of spontaneous abortions associated 
with exposure to TOL in the workplace (Lindbohm et al., 1990; Ng et al., 1992; Taskinen et 
al., 1994). Intra-uterine growth retardation and craniofacial defects have been observed in 
children whose mothers had sniffed glues or paints containing TOL, during pregnancy 
(Wilkins-Haug, 1997). Prenatal inhalation studies in rats have shown that TOL can induce 
lower fetal and birth weight, delayed postnatal development and behavioural changes in pups. 
In a study using currently accepted international procedure, Sprague-Dawley rats were 
exposed 250, 750, 1500 or 3000 ppm TOL, 6 h day-1, from GD 6 to GD 15 (American 
Petroleum Institute, 1993). Maternal toxicity, evidenced by reduced body weight and food 
consumption, was seen at 3000 ppm. Lower weight change during the two first days of 
treatment and clinical signs of reaction to exposure were also observed at 1500 ppm. 
Developmental effects were confined to 1500 and 3000 ppm and consisted of a decrease in 
fetal weight and an increased incidence of fetuses with a skeletal variation (i.e. reduced 
ossification of sternebrae). 
n-Butyl acetate (BA) is mainly used as a solvent and a thinner in the production of 
nitrocellulose lacquers in the protective coatings industry (World Health Organization, 2005). 
It is also used in the manufacture of highpolished lacquers and varnishes, and as component in 
food flavours and packaging. The estimated production of BA in the USA was 150 000 tonnes 
in 1997. Little information is available on the prenatal effects of BA. Pregnant New Zealand 
White rabbits and Sprague-Dawley rats were administered BA by inhalation, 7 h day-1, at a 
single concentration of 1500 ppm (Hackett et al., 1982). In rabbits, exposure to BA from GD 
1 to 19 caused an increased incidence of fetuses with morphological changes, including retina 
folds, misaligned sternebrae and gallbladder variations. No major malformations were 
observed. In rats, prenatal exposure to BA resulted in fetal growth retardation (i.e. body 
weight, crown–rump length). A higher incidence of fetuses with rib alterations was seen after 
exposure on GD 7–16, and there was an increased incidence of hydroureter in fetuses of rats 
treated pregestationally and subsequently, on GD 1–16. These developmental effects occurred 
in the presence of maternal toxicity, in both species. 
TOL, EB and BA have been detected in household and workplace air (World Health 
Organization, 1996; 2005). They are generally used in mixtures with other solvents in 
domestic or industrial products (e.g. varnishes). Thus, occupational exposure to mixtures of 
EB, TOL and/or BA have been reported in workplaces involving painting or lacquering 
(Vincent et al., 1994; Muttray et al., 1995; Seeber et al., 1996; Jovanovic et al., 2004). 
Inhalation is the most likely route of exposure for workers and the general population, due to 
the volatility of these chemicals. 
The objectives of the study reported here were: (1) to further evaluate the developmental toxic 
potential of inhaled BA in rats, and (2) to determine the prenatal effects of the binary solvent 
mixtures, EB and BA, and TOL and BA. 
 
Materials and Methods 
Chemicals 
Ethylbenzene (EB, CAS 100-41-4, >=99.5% pure), n-butyl acetate (BA, CAS 123-86-4, 
>=99.0% pure) and toluene (TOL, CAS 108-88-3, >=99.7% pure) were purchased by Fluka 
Chemie AG (Buchs, Switzerland). 
 
Animals 
After 2 weeks of acclimatization, nulliparous female (180– 200 g) Sprague-Dawley rats 
supplied by IFFA CREDO Breeding Laboratories (Saint-Germain-sur-l’Arbresle, France) 
were housed overnight with adult males (one male: two or three females) from the same strain 
and supplier. The day that vaginal smears were found to be sperm-positive was considered as 
day 0 of gestation. Mated females were randomly assigned to the treatment groups using a 
randomization system stratified by body weight on GD 0. Mated females were housed singly 
in clear polycarbonate cages with stainless-steel wire lids and corn cob granules as bedding in 
rooms maintained at 21 ± 2 °C, a relative humidity of 50 ± 5%, and a 12 h light-dark 
photocycle. For exposures, the females were transferred to stainless-steel wire mesh exposure 
cages, and the cages were moved into the chambers. After each exposure, the animals 
returned to their original cages and ‘home’ rooms. Food pellets (UAR Alimentation 
Villemoisson, France) and filtered tap water were available ad libitum except during 
exposures. 
 
Experimental Design 
Three developmental toxicity experiments have been carried out: In the first experiment, the 
effects of BA alone were investigated. Groups of 21–22 bred rats (19– 21 pregnant) were 
exposed to 0 (control), 500, 1000, 2000 or 3000 ppm of BA, 6 h day-1, on days 6–20 of 
gestation. These concentrations were based on the study of David et al. (2001) and on a short 
term preliminary study in which non-pregnant rats exposed to 500 or 1500 ppm BA, 6 h day-
1, for 15 days showed no changes in serum (e.g. aspartate aminotransferase and alanine 
aminotransferase activities, urea, creatinine) and urinary (e.g. proteins) markers of hepatic and 
kidney damage, and in histology of the liver and kidney. 
In the second experiment, the combined effects of EB and BA were investigated. Groups of 
18 bred rats (15– 18 pregnant) were exposed to vapours of EB or BA, separately or in 
combination, 6 h day-1, on days 6–20 of gestation. There were nine experimental groups: 
Control; 250 or 1000 ppm EB; 500 or 1500 ppm BA or mixtures of 250 ppm EB + 500 ppm 
BA, 250 ppm EB + 1500 ppm BA, 1000 ppm EB + 500 ppm BA, or 1000 ppm EB + 1500 
ppm BA. 
In the third experiment, the combined effects of toluene and BA were investigated. Groups of 
18–19 bred rats (13–19 pregnant) were exposed to vapours of toluene or BA, separately or in 
combination, 6 h day-1, on days 6–20 of gestation. There were nine experimental groups: 
Control; 500 or 1500 ppm toluene; 500 or 1500 ppm BA or mixtures of 500 ppm toluene + 
500 ppm BA, 500 ppm toluene + 1500 ppm BA, 1500 ppm toluene + 500 ppm BA, or 1500 
ppm toluene + 1500 ppm BA. 
Concentrations were selected based on the results from the first experiment for BA, on a 
previous study conducted in the same laboratory for EB (Saillenfait et al., 2003), and on the 
study of the American Petroleum Institute (1993) for toluene. No maternal and developmental 
effects were expected at 250 ppm EB, 500 ppm toluene, or 500 ppm BA, and mild toxicity at 
1000 ppm EB, 1500 ppm toluene, or 1500 ppm BA. 
Control animals were exposed concurrently to filtered room air in an adjacent chamber 
identical to those of the treatment groups. 
 
 
Generation of Test Atmospheres 
Exposures were conducted in 200 l glass/stainless-steel inhalation chambers with dynamic 
and adjustable laminar air flow (5–10 m3 h-1). In order to prevent any leakage of the test 
atmospheres, the chambers were maintained at a negative pressure of no more than 3 mm 
water. The chamber temperature was maintained within the range of 21–25 °C and the 
relative humidity within 30–70%. Chemical vapours were generated by passing an additional 
airflow through the fritted disk of a heated bubbler containing either of the test chemicals. 
Under these conditions the vaporized compounds were carried out into the main air inlet pipe 
of the exposure chambers. 
 
Atmosphere Sampling and Analysis 
Concentrations of EB and BA, or toluene and BA were monitored continuously with a gas 
chromatograph (Shimadzu GC14B model and Perkin Elmer autosystem XL) equipped with a 
flame ionization detector and an automatic gas-sampling valve. The column temperature was 
maintained at 150 °C. In addition, the exposure levels were determined once during the 6 h 
exposure period by collecting atmosphere samples through glass tubes packed with activated 
charcoal, in the breathing zone of the test animals. EB, toluene and/or BA were then desorbed 
with carbon disulfide and analysed on a Shimadzu GC-8A gas chromatograph, using toluene, 
ethylbenzene and n-propyl acetate as internal standards, respectively. Samples were 
chromatographed on a 4 m long column packed with PEG 20 M. Because the concentration 
determined by analyses was essentially the same as the target concentration, it will be referred 
to the target concentration in this paper (Table 1). 
 
Table 1. Mean analytical concentrations of compounds in exposure chambers 
 
 
 
 
Maternal and Fetal Evaluations 
Females were observed daily for clinical signs, before and at the end of the exposure period. 
Maternal body weights were recorded on GD 0, 6, 13 and 21. In addition, in the first 
experiment, food consumption was measured for the intervals GD 6–13 and 13–21. On GD 
21, the females were killed with an intrapulmonary injection of T61 (Hoechst, Frankfurt, 
Germany). The uterus was then removed and weighed. The number of corpora lutea, 
implantation sites, resorptions and dead and live fetuses were recorded. Uteri which had no 
visible implantation sites were stained with ammonium sulfide (10%) to detect very early 
resorptions (Salewski, 1964). Live fetuses were weighed, sexed and examined for external 
anomalies including those of the oral cavity. Half of the live fetuses from each litter was 
preserved in Bouin’s solution and examined for internal soft tissue changes (Wilson, 1965; 
Barrow and Taylor, 1969). The other half was fixed in ethanol (70%), eviscerated, and then 
processed for skeletal staining with alizarin red S for subsequent skeletal examination (Staples 
and Schnell, 1964). 
 
Statistical Analysis 
Whenever possible, the data were presented as mean ± SD. The litter was used as the basis for 
analysis of fetal variables. 
 
Developmental Toxicity Study on BA Alone 
The number of implantation sites and live fetuses and various body weights were analysed by 
one-way analysis of variance, followed by Dunnett’s test if differences were found. The 
frequency of post-implantation loss, dead fetuses, resorptions and alterations among litters 
was evaluated by using the Kruskal-Wallis test followed by the Mann-Whitney test where 
appropriate. Rates of pregnancy, and the proportions of fetuses and litters with malformations 
(any), or variations (external, visceral, skeletal, and any) in the treated groups were compared 
with those of the control group by the Fisher’s test. Where applicable, least-squares analysis 
was carried out. The reported level of statistical significance was P < 0.05. 
 
Studies on the Mixtures 
A large number of data sets did not show homogeneity of variance (Bartlett’s test). Therefore, 
all data were analysed using a nonparametric analysis of variance (Kruskal-Wallis test), 
followed by the Mann-Whitney test for multiple comparisons among the treatment groups, 
when significance was indicated (P < 0.05). Interactions between EB and BA, and between 
TOL and BA, were analysed by two-way analysis of variance on ranks. 
 
Results 
Developmental Toxicity Study on BA Alone 
Maternal weight gain was significantly decreased at 2000 and 3000 ppm during the entire 
exposure period (Table 2). Corrected weight gain was also reduced at these concentrations. A 
significant decrease in food consumption was observed during the first half of treatment at 
1000 ppm and throughout exposure at 2000 and 3000 ppm (Table 3). Treatment had no effect 
on the number of implantations and live fetuses, or on the  incidence of non-live implants and 
resorptions per litter (Table 4). Fetal body weight was slightly lower than the control at 2000 
ppm and was significantly reduced at 3000 ppm (3% and 12–13% less than control, 
respectively). Malformations were seen in single fetuses in the 1000 and 2000 ppm groups, 
but none at the highest exposure group of 3000 ppm (Table 5). Several common external and 
visceral variations were observed with no indication of treatment-related effects. The 
percentage of fetuses with skeletal variations was significantly elevated at 1000 ppm. 
However, these changes did not follow a concentration-response relationship and none of the 
individual skeletal variations was significantly different from control. 
 
 
 
 
Table 2. Body weight gain of dams after inhalation exposure to butyl acetate 
 
 
 
Table 3. Food consumption of dams after inhalation exposure to butyl acetate 
 
 
 
 
Table 4. Reproductive parameters in rats after inhalation exposure to butyl acetate 
 
 
 
Table 5. Malformations and variations in fetuses of rats after inhalation exposure to butyl acetate 
 
 
 
Developmental Toxicity Study on EB and BA Mixture 
 
No significant changes in maternal weight gain and corrected weight gain was observed after 
exposure to the EB or BA at the lowest concentration (i.e. 250 and 500 ppm, respectively), 
either alone or after co-exposure (Table 6). These parameters were significantly different from 
control at the high concentrations of EB (1000 ppm) and BA (1500 ppm), alone and in 
combinations with the other solvent. There was no effect of treatment on the mean number of 
implantations and of live fetuses, and on the incidence of non-live implants and resorptions 
(Table 7). Fetal body weight was significantly decreased after exposure to 1000 ppm EB 
alone, or either mixture. Single cases of external, visceral and skeletal malformations (i.e. 
exencephaly, cleft lip and palate, diaphragmatic hernia, anal atresia, absent ribs and vertebrae, 
fused vertebrae) were seen scattered among the groups. No increase in the incidences of 
external (i.e. club foot) and visceral variations (i.e. dilated renal pelvis, distended ureter) was 
observed (Table 8). There were no changes in the mean percentage of fetuses with skeletal 
variations per litter or in the incidence of individual skeletal variations (Table 9). The only 
statistically significant differences were higher overall percentages of fetuses with skeletal 
variations in four groups compared with the concurrent control: 250 ppm EB, 1500 ppm BA, 
1000 ppm EB with 500 ppm BA, and 1000 ppm EB with 1500 ppm BA. 
Two-way ANOVA analysis indicated no significant interaction between EB and BA for 
maternal and reproductive parameters. The decreases in maternal and fetal weights induced by 
co-administration of EB with BA were roughly comparable to the summation of the 
individual chemical responses. Thus, the reduction of fetal weight amounted to 7% at 1000 
ppm EB, 3% at 1500 ppm BA, and 12% following co-exposure to 1000 ppm EB with 1500 
ppm BA. 
 
Table 6. Body weight gain of dams after inhalation exposure to ethylbenzene and butyl acetate, alone or in 
Combinations 
 
 
Table 7. Reproductive parameters in rats after inhalation exposure to ethylbenzene and butyl acetate, alone or in 
Combinations 
 
 
Table 8. Overall incidence of malformations and variations in fetuses of rats after inhalation exposure to 
ethylbenzene and butyl acetate, alone or in 
Combinations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Developmental Toxicity Study on Toluene and BA Mixture 
No significant changes in maternal weight gain and corrected weight gain was observed after 
exposure to the TOL or BA at the lowest concentration (i.e. 500 and 500 ppm, respectively), 
alone or following co-exposure (Table 10). These parameters were significantly different 
from the control at the high concentrations of TOL (1500 ppm) and BA (1500 ppm), alone 
and in combinations with either levels of the other solvent. Whatever treatment group, no 
adverse effect on the average number of implantations and of live fetuses, or incidence of 
non-live implants and resorptions was noted (Table 11). The fetal body weight was 
significantly lower than the control after exposure to 1500 ppm TOL, alone or in combination 
with BA. It was also significantly different after treatment with BA alone at 1500 ppm. 
Although this effect was more pronounced than it might have been expected from the other 
experiments conducted in the laboratory, it remained small in magnitude (reduction of 4% 
compared with control). Malformations (mainly diaphragmatic hernia) were observed 
sporadically in treatment groups (Table 12). They occurred in no more than one or two fetuses 
per group and did not show a specific pattern. There was no significant change in the 
occurrence of any individual external, visceral and skeletal variations. The total incidences of 
fetuses with visceral and/or skeletal variations were significantly lower than the concurrent 
control in several treatment groups. These findings were attributed to biological variations and 
were not considered of toxicological significance. 
No statistically significant interaction between TOL and BA was found regarding maternal 
weight gain and reproductive parameters. Reductions of maternal weight gain and fetal weight 
were not greater after co-exposure to TOL and BA, compared with the solvents alone. Thus, 
the reduction of fetal weight amounted to 7% at 1500 ppm TOL, 4% at 1500 ppm BA, and 
11% following co-exposure to 1500 ppm TOL with 1500 ppm BA. 
 
Table 9. Skeletal variations in fetuses of rats after inhalation exposure to ethylbenzene and butyl acetate, alone 
or in combinations 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 10. Body weight gain of dams after inhalation exposure to toluene and butyl acetate, alone or in 
combinations 
 
 
 
Table 11. Reproductive parameters in rats after inhalation exposure to toluene and butyl acetate, alone or in 
Combinations 
 
 
 
Table 12. Overall incidence of malformations and variations in fetuses of rats after inhalation exposure to toluene 
and butyl acetate, alone or in combinations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
The present results indicated that exposure of pregnant rats to vapours of BA during the 
embryonic and fetal period did not result in selective developmental toxicity. Exposure to 
2000 or 3000 ppm BA resulted in maternal toxicity, as evidenced by reduced food 
consumption and weight gain. At 1000 ppm, the only evidence of a maternal effect was a 
transient decrease in food consumption. Fetal toxicity consisting of reduced fetal body weight, 
was observed at 2000 and 3000 ppm. This effect was minimal and non-significant at 2000 
ppm. The absence of teratogenic and embryolethal effects up to maternal toxic concentrations 
is in good agreement with the results of a previous study by Hackett et al. (1982), in which 
groups of 37–42 Sprague-Dawley rats were exposed to a single concentration of 1500 ppm 
BA, 7 h day-1, on GD 1–19, GD 7–GD 19, or 3 weeks prior to mating and daily from GD 1–
GD 16. Maternal food consumption and body weight gain, and fetal weight were reduced, 
whatever the period of treatment. Exposure during GD 1–19 or GD 7–19 also produced a 
slight increase in the incidence of rib dysmorphology (i.e. wavy, fused, bifid ribs) and reduced 
pelvic ossification. However, similar effects were not seen in the group exposed during this 
period of gestation, subsequent to a pregestational exposure. Thus, Hackett et al. (1982) did 
not consider these rib alterations as indicative of a teratogenic potential. It is expected that BA 
is readily absorbed by the respiratory tract and hydrolysed to n-butanol. Sprague-Dawley rats 
were exposed to 3500, 6000 or 8000 ppm n-butanol, 7 h day-1, on days 1–19 of gestation 
(Nelson et al., 1989). Maternal toxicity and reduced fetal weight were observed at the two 
highest concentrations. An increased incidence of fetal skeletal alterations (mainly 
rudimentary cervical ribs) also occurred at 8000 ppm. These findings suggest that the acetate 
ester is more potent than its corresponding alcohol regarding maternal and developmental 
toxicity. Kinetic factors may have accounted for these differences. Barton et al. (2000) have 
developed a pharmacokinetic model for BA and its metabolites and assumed a NOAEL of 
500 ppm for 6 h day-1 inhalation to BA, based on subchronic and neurotoxicity studies 
(David et al., 1998; 2001). They estimated that a higher exposure concentration of 820 ppm n-
butanol was necessary to achieve blood levels similar to those resulting from exposure to 500 
ppm BA. This was attributed to a lower respiratory tract absorption. 
The current study also examined the prenatal effects of the mixtures EB with BA, and TOL 
with BA, following simultaneous exposures during the period of organogenesis and late 
gestation. As expected from previous studies (American Petroleum Institute, 1993; Saillenfait 
et al., 2003), no significant toxic effects were observed at 250 ppm EB or 500 ppm TOL, 
when they were administered individually. A fetal toxicity limited to a reduction of fetal 
weight, and a reduction of maternal weight gain were observed after treatment with 1000 ppm 
EB or 1500 ppm TOL, alone. The spectrum of the developmental toxic effects produced by 
either of the three solvents was not modified by co-exposures, and no increase in prenatal 
mortality or malformations was observed, whatever the treatment regimen. Results from the 
mixture of EB with BA indicated that co-exposure may cause developmental toxicity, even 
when each component is present at a concentration that individually produces insignificant 
effects (i.e. decrease in fetal weight by 250 ppm EB and 500 ppm BA). Nevertheless, the 
reduction of maternal and fetal weight produced by the combinations of EB with BA, and of 
TOL with BA, corresponded to the effects expected on the basis of a simple additivity. 
Although the decrease in fetal weight could be attributed to both components of the mixtures, 
EB and TOL were more effective than BA, when they were administered alone. The effects of 
combined ethylbenzene and methylethylketone (MEK) have been studied in Sprague-Dawley 
rats, following inhalation, for 6 h day-1, during days 6–20 of gestation (Saillenfait et al., 
2006). No evidence of interaction between EB and MEK was found regarding developmental 
toxicity. However, apparently greater than additive effects were demonstrated for several 
maternal endpoints. They were mostly evident at the highest concentrations of the mixture 
(i.e. 1000 ppm ethylbenzene with 3000 ppm methylethylketone). Taken together, these 
findings provide support to the default assumption of additivity for the developmental toxic 
effects of these toxicants, at low inhalation exposure levels. However, it cannot be excluded 
that interactions might occur under other treatment conditions (e.g. route of administration, 
doses). In that regard, more extensive characterization of the mixtures’ dose-response 
relationships might be developed. 
In summary, the results of our inhalation study provide no significant evidence of interactions 
among the solvents tested (i.e. two aromatic hydrocarbons with an acetate ester), based upon 
standard maternal and embryo/fetal endpoints. The evaluation of the developmental hazards 
due to mixtures of solvents is complicated by the paucity of data, and by the complexity and 
multiplicity of exposures encountered in the working environments. The toxicological 
responses of other solvent combinations need to be considered. 
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